# Brittany Johnson

Type: Person

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/brittany-johnson
Canonical HTML page: https://getbiobrief.com/entity/brittany-johnson

## Recent coverage (1 stories)

### ALS patient's 1-year decline spotlights 90% sporadic case urgency for biopharma
2026-08-07 05:59:21 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

The devastating speed of Chris Johnson’s sporadic ALS—from an elite athlete to eye-controlled communication in a year—exposes the profound unmet need in neurodegenerative drug development. With current therapies offering only months of survival benefit, the biopharma sector faces immense pressure to deliver disease-modifying treatments.
Full story: https://getbiobrief.com/story/chris-johnson-als-diagnosis-biopharma-opportunity

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.